Cargando…
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
Hepatocellular carcinoma (HCC) is a heterogeneous disease with a poor prognosis and limited markers for predicting patient survival. Because chemokines and chemokine receptors play numerous and integral roles in HCC disease progression, the CXCR4–CXCL12–CXCR7 axis was studied in HCC patients. CXCR4...
Autores principales: | Neve Polimeno, Maria, Ierano, Caterina, D'Alterio, Crescenzo, Simona Losito, Nunzia, Napolitano, Maria, Portella, Luigi, Scognamiglio, Giosuè, Tatangelo, Fabiana, Maria Trotta, Anna, Curley, Steven, Costantini, Susan, Liuzzi, Raffaele, Izzo, Francesco, Scala, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496532/ https://www.ncbi.nlm.nih.gov/pubmed/25363530 http://dx.doi.org/10.1038/cmi.2014.102 |
Ejemplares similares
-
Inhibition of stromal CXCR4 impairs development of lung metastases
por: D’Alterio, Crescenzo, et al.
Publicado: (2012) -
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020) -
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
por: Portella, Luigi, et al.
Publicado: (2013) -
CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
por: Circelli, Luisa, et al.
Publicado: (2016) -
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)